Soriatane© (Acitretin)
Content:
INDICATIONS
Psoriasis
- Approved by the FDA for use in psoriasis in 1997
- Used in monotherapy to treat generalized pustular, localized pustular and erythrodermic psoriasis
- More effective at treating severe plaque-type psoriasis when used in combination with other treatments
Off-Label Uses
- Darier’s disease
- Ichthyosiform erythroderma
- Lamellar ichthyosis
- Erythrokeratoderma variabilis
- Lichen planus
- Sjogren-Larsson Syndrome
- Pityriasis rubra pilaris
- Palmoplantar pustulosis
- Post-transplantation: to reduce squamous cell carcinomas
Click here for more information on Off-Label Uses
Next: Patient Profile
More Presentations:
Patient Guides:
Acne| Botox| Cold Sores| Cosmetic Surgery/Procedures| Dermatologists Canada| Skin Care Tips| Eczema| Fungal Infections| Herpes| Lice| Skin Cleansers| Mohs Surgery| Psoriasis| Psoriatic Arthritis| Rosacea| Skin Cancer| Skin Pharmacies| Sweating| Unwanted Facial Hair